Covaxin Bharat Biotech Update

Bharat Biotech's Covaxin Shows Promising Results | Coronavirus Vaccine Update

Coronavirus Update: Animal Trials Of Bharat Biotech COVID-19 vaccine Covaxin Successful

Bharat Biotech's Covaxin: All You Need To Know About Covid Vaccine | India Today

Covid-19 updates: Bharat Biotech Completes Phase 2/3 Trials of Covaxin For Children

The Indian Express

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

WION

Covid Vaccine Update| First Batch Of Bharat Biotech's Covaxin To Arrive In Delhi Shortly| Breaking

Covid vaccine: Bharat Biotech ends deal with Brazil; EU approves Moderna for kids

Hindustan Times

India's first indigenous vaccine 'Covaxin' gets expert panel's nod | Bharat Biotech | World News

WION

Coronavirus Vaccine| Bharat Biotech's Top Brass Slams Covaxin Critics| Covid-19 News | Covid Vaccine

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking

Bharat Biotech's Covaxin Goes For WHO Nod Tomorrow | Breaking News | India Today

COVID vaccine updates: Bharat Biotech's Covaxin displayed long-term antibody response

Coronavirus Vaccine Update: Bharat Biotech Plans Likely To Launch Covaxin Post March 2021

Study: Covaxin developed by Indian Pharma firm Bharat Biotech neutralizes UK variant | COVID-19

WION

Bharat Biotech's Covaxin Show Promising Results; Well Tolerated In All Groups In Phase 1 & 2 Trials

Bharat Biotech's Covaxin Assures Beneficiaries Of Compensation In Case Of Adverse Effects

Bharat Biotech's Covaxin Recommended By Expert Panel For Phase 2/3 Trials On Children

Covaxin for kids: Bharat Biotech completes phase 2/3 trials, to submit data to DCGI next week

The Economic Times

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trials

WHO Recognizes Bharat Biotech's Covaxin | India Today